Attached files
| file | filename |
|---|---|
| 8-K - 8-K - SEELOS THERAPEUTICS, INC. | a8-kforchangeinaccountingf.htm |
Exhibit 16.1
March 23, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549-7561
Commissioners:
We have read the statements made by Apricus Biosciences, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part the Form 8-K of Apricus Biosciences, Inc. dated March 18, 2015. We agree with the statements concerning our Firm in such 8-K.
Very truly yours,
/s/ PricewaterhouseCoopers LLP